Antibody-drug conjugate boasts high remission rates in AML

Copenhagen – Among older adults with acute myeloid leukemia, the combination of a drug-antibody conjugate and hypomethylating therapy was associated with high complete remission rates. In a <a...
Source: Family Practice News - Category: Primary Care Source Type: news